Commentaries on "Insulin Resistance, Affective Disorders, and Alzheimer's Disease: Review and Hypothesis" and Authors' Response

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 59, Issue 2, 2004, Pages 184-185

  Banks, William A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPSIN; AGOUTI RELATED PROTEIN; AMYLOID BETA PROTEIN; CHOLECYSTOKININ; CYTOKINE; GLUCOSE; GLUCOSE TRANSPORTER 1; INSULIN; LEPTIN; REGULATOR PROTEIN; RESISTIN;

ALZHEIMER DISEASE; COGNITIVE DEFECT; DEPRESSION; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MOOD DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; PRIORITY JOURNAL;

AGOUTI;

EID: 1442282353     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (15)

1. Banks WA, Morley JE. Memories are made of this: recent advances in understanding cognitive impairments and dementia. J Gerontol Med Sci. 2003;58A:314-321.
2. Grossberg GT, Desai AK. Management of Alzheimer's disease. J Gerontol Med Sci. 2003;58:331-353.
3. Blazer DG. Depression in late life: review and commentary. J Gerontol Med Sci. 2003;58A:249-265.
4. Rasgon N, Jarvik L. Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. J Gerontol Med Sci. 2004;59A:178-183.
5. Morley JE. Minireview: The ascent of cholecystokinin (CCK)-from gut to brain. Life Sci. 1982;30:479-493.
6. Bloom SR. Gut and brain-endocrine connections. The Goulstonian Lecture 1979. J Royal Coll Phys London. 1980;14:51-57.
7. Woods SC, Porte D Jr. Relationship between plasma and cerebrospinal fluid insulin levels of dogs. Am J Physiol. 1977;233: E331-E334.
8. Kastin AJ, Plotnikoff NP, Sandman CA, et al. The effects of MSH and MIF on the brain. In: Stumpf WE, Grant LD, eds. Anat Neuroendocrinol. Basel: Karger, 1975:290-297.
9. Woods SC, Seeley RJ, Baskin DG, Schwartz MW. Insulin and the blood-brain barrier. Curr Pharm Des. 2003;9:795-800.
10. Kelley KW, Bluthe RM, Dantzer R, et al. Cytokine-induced sickness behavior. Brain Behav Immun. 2003;17:S112-S118.
11. Banks WA. Is obesity a disease of the blood-brain barrier? Physiological, pathological, and evolutionary considerations. Curr Pharm Des. 2003;9:801-809.
12. Zimanyi IA, Pelleymounter MA. The role of melanocortin peptides and receptors in regulation of energy balance. Curr Pharm Des. 2003;9: 627-642.
13. De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med. 1991;325:703-709.
14. Banks WA, Kastin AJ. Physiological consequences of the passage of peptides across the blood-brain barrier. Rev Neurosci. 1993;4: 365-372.
15. Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA. Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun. 2003;17:276-285.